Call Us
+919327127459
Contact Us For Help
Products
Ledipasvir and Sofosbuvir Tablets

Ledipasvir and Sofosbuvir Tablets

258 USD ($)

Product Details:

  • Dosage As Directed By Physician.
  • Dosage Guidelines As Directed By Physician.
  • Suitable For Adults
  • Storage Instructions Store in a cool and dark place.
  • Supply Ability : 1000000 Box Per Month
  • Click to view more
X

Price And Quantity

  • As required by client. Box
  • 258 USD ($)

Product Specifications

  • As Directed By Physician.
  • Store in a cool and dark place.
  • As Directed By Physician.
  • Adults

Trade Information

  • Hazira / Nhava Sheva
  • Cash Advance (CA), Cash in Advance (CID), Telegraphic Transfer (T/T)
  • 1000000 Box Per Month
  • 1-2 Week
  • Yes
  • If order is confirmed we will reimburse the sample cost
  • Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa
  • WHO-GMP/ GMP/ COA/ As Required By Client

Product Description

Product Details:

Brand

SOFOCRUZ LP


We Salvavidas Pharmaceutical Pvt Ltd are a leading Manufacturer and Exporter of SOFOCRUZ LP TABLET  (Sofosbuvir 400mg + Ledipasvir 90mg ) in different strength and packing. Our manufacturing facility is certified with WHO-GMP.

COMPOSITION :

SOFOCRUZ LP TABLET  (Sofosbuvir 400mg + Ledipasvir 90mg )
  • Brand name: SOFOCRUZ LP
  • Active Ingredients(Generic Name) : Sofosbuvir 400mg + Ledipasvir 90mg
  • Company Name: Torrent Pharmaceuticals Ltd
  • Strength : 400 mg + 90 mg
  • Package: 28 tabs
  • Pack Type: Bottle
Indication:

SOFOCRUZ LP  Contain Sofosbuvir and Ledi pasvir For the treatment of Hepatitis C.
Hepatitis C is a liver disease caused by the hepatitis C virus the virus can cause both acute and chronic hepatitis infection, ranging in severity from a mild illness lasting a few weeks to a serious, lifelong illness.
  • The hepatitis C virus is a blood borne virus and the most common modes of infection are through unsafe injection practices, inadequate sterilization of medical equipment, and the transfusion of unscreened blood and blood products.
  • Globally, between 130-150 million people globally have chronic hepatitis C infection.
  • A significant number of those who are chronically infected will develop liver cirrhosis or liver cancer.
  • There is currently no vaccine for hepatitis C; however, research in this area is ongoing.
The hepatitis C virus is a blood borne virus. It is most commonly transmitted through:
  • injecting drug use through the sharing of injection equipment;
  • the reuse or inadequate sterilization of medical equipment, especially syringes and needles in healthcare settings; and
  • The transfusion of unscreened blood and blood products.
Uses:-
Treating chronic hepatitis C virus (HCV) infection in certain patients.
Ledipasvir and sofosbuvir is a combination of 2 hepatitis C virus (HCV) antiviral agents. It reduces the amount of HCV in the body by preventing the spread of the HCV within the body.

Available other Brand: HEPCINAT LP, LEDIFOS, RESOF L, LEDVICLEAR, MYHEP LVIR, HEPCVIR L, SOFOCURE L, NOVISOF L, LEDIHEP, SOFAB LP, LEDVICLEAR, SOFOKEM L, CIMIVIR 
Enter Buying Requirement Details
Email Id
Mobile number

Other Products in 'Hepatitis C Medicine' category